Salud financiera de hoja de balance de Consun Pharmaceutical Group
Salud financiera controles de criterios 6/6
Consun Pharmaceutical Group tiene un patrimonio de accionistas total de CN¥4.0B y una deuda total de CN¥507.7M, lo que sitúa su ratio deuda-patrimonio en 12.7%. Sus activos y pasivos totales son CN¥5.5B y CN¥1.5B respectivamente. El BAIT de Consun Pharmaceutical Group es de CN¥882.9M, por lo que su ratio de cobertura de intereses es de -16.8. Tiene efectivo e inversiones a corto plazo que ascienden a CN¥3.6B.
Información clave
12.7%
Ratio deuda-patrimonio
CN¥507.70m
Deuda
| Ratio de cobertura de intereses | -16.8x |
| Efectivo | CN¥3.58b |
| Patrimonio | CN¥3.99b |
| Total pasivo | CN¥1.50b |
| Activos totales | CN¥5.49b |
Actualizaciones recientes sobre salud financiera
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet
Jun 12
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet
May 04Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly
Apr 21Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly
Dec 18Recent updates
Consun Pharmaceutical Group Limited's (HKG:1681) Shares Leap 32% Yet They're Still Not Telling The Full Story
Oct 02Here's Why Consun Pharmaceutical Group (HKG:1681) Has Caught The Eye Of Investors
Sep 26Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet
Jun 12Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30
May 12Consun Pharmaceutical Group (HKG:1681) Is Increasing Its Dividend To CN¥0.30
Jun 01Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet
May 04Consun Pharmaceutical Group (HKG:1681) Will Pay A Dividend Of HK$0.20
Apr 28Consun Pharmaceutical Group (HKG:1681) Has Announced A Dividend Of HK$0.20
Apr 07Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10
Aug 26Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly
Apr 21Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?
Mar 17Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative
Feb 19How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 29Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?
Jan 08
Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly
Dec 18Should Consun Pharmaceutical Group Limited (HKG:1681) Be Part Of Your Income Portfolio?
Nov 18Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (CN¥4.2B) de 1681 superan a sus pasivos a corto plazo (CN¥1.4B).
Pasivo a largo plazo: Los activos a corto plazo de 1681 (CN¥4.2B) superan a sus pasivos a largo plazo (CN¥112.5M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 1681 tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de 1681 ha pasado de 27.7% a 12.7% en los últimos 5 años.
Cobertura de la deuda: La deuda de 1681 está bien cubierta por el flujo de caja operativo (180.3%).
Cobertura de intereses: 1681 gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.